Mabion SA sell "MabionCD20"
Basic Information
1.3K
102
28
3.7(48)
Category
Subcategory & Sub-subcategory
Trade Type
Sell
Product Name
MabionCD20
Specifications
- Application: Developed as a biosimilar intended to demonstrate high similarity to an approved reference biologic product.
- Country of Origin: Poland
- Regulatory Status: In final-stage preparation to market in Europe and the United States as a biosimilar to rituximab (MabThera/Rituxan), with clinically confirmed efficacy and safety.
Documents
Other
GMP
ISO
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Matched Products & Services
B2B matches based on trade type, category, specifications & price range
Similar Products & Services
Products & Services related to what you're viewing
People Also Viewed
Other products & services viewed by people who looked at this product
Leave your rating & comment